Bristol-Myers Squibb News
Most Popular Bristol-Myers Squibb Story
New BMS CEO gets 89% raise
Bristol-Myers Squibb CEO Jim Cornelius didn't fare too badly during his last full year on the job: According to the company's preliminary proxy statement, his pay dropped a bit, to $18.2 million from... Read more...
Latest Headlines
- March 15, 2010
- March 10, 2010
- March 5, 2010
- March 4, 2010
- March 2, 2010
- February 4, 2010
- January 29, 2010
- January 28, 2010
- December 23, 2009
- December 21, 2009
- December 14, 2009
- December 9, 2009
- November 24, 2009
- November 18, 2009
- November 16, 2009
- November 13, 2009
- November 13, 2009
- November 5, 2009
- November 3, 2009
- October 23, 2009
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
